カテゴリー： Market Monitor Global, 世界, 医療/バイオ

水痘ウイルス生ワクチンの世界市場見通し2023年-2029年

◆英語タイトル：Varicella Virus Vaccine Live Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8737 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月 ◆ページ数：72 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Varicella Virus Vaccine Live Market 調査レポートは次の情報を含め、グローバルにおけるの水痘ウイルス生ワクチン市場規模と予測を収録しています。・世界の水痘ウイルス生ワクチン市場：売上、2018年-2023年、2024年-2029年
・世界の水痘ウイルス生ワクチン市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の水痘ウイルス生ワクチン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「子供」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

水痘ウイルス生ワクチンのグローバル主要企業は、GSK、 Merck、 Sanofi、 Green Cross、 Shanghai Institute、 BCHT、 Changsheng、 Keygen、 Bikenなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、水痘ウイルス生ワクチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の水痘ウイルス生ワクチン市場：タイプ別、2018年-2023年、2024年-2029年
世界の水痘ウイルス生ワクチン市場：タイプ別市場シェア、2022年
・子供、大人

世界の水痘ウイルス生ワクチン市場：用途別、2018年-2023年、2024年-2029年
世界の水痘ウイルス生ワクチン市場：用途別市場シェア、2022年
・政府機関、民間、その他

世界の水痘ウイルス生ワクチン市場：地域・国別、2018年-2023年、2024年-2029年
世界の水痘ウイルス生ワクチン市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における水痘ウイルス生ワクチンのグローバル売上、2018年-2023年
・主要企業における水痘ウイルス生ワクチンのグローバル売上シェア、2022年
・主要企業における水痘ウイルス生ワクチンのグローバル販売量、2018年-2023年
・主要企業における水痘ウイルス生ワクチンのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
GSK、 Merck、 Sanofi、 Green Cross、 Shanghai Institute、 BCHT、 Changsheng、 Keygen、 Biken

*************************************************************

・調査・分析レポートの概要
水痘ウイルス生ワクチン市場の定義
市場セグメント
世界の水痘ウイルス生ワクチン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の水痘ウイルス生ワクチン市場規模
世界の水痘ウイルス生ワクチン市場規模：2022年 VS 2029年
世界の水痘ウイルス生ワクチン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの水痘ウイルス生ワクチンの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の水痘ウイルス生ワクチン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：子供、大人
水痘ウイルス生ワクチンのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：政府機関、民間、その他
水痘ウイルス生ワクチンの用途別グローバル売上・予測

・地域別市場分析
地域別水痘ウイルス生ワクチン市場規模 2022年と2029年
地域別水痘ウイルス生ワクチン売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
GSK、 Merck、 Sanofi、 Green Cross、 Shanghai Institute、 BCHT、 Changsheng、 Keygen、 Biken
...

Varicella virus live vaccine is an active immunizing agent that is given to protect against infection caused by the varicella-zoster virus (VZV).
This report aims to provide a comprehensive presentation of the global market for Varicella Virus Vaccine Live, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Varicella Virus Vaccine Live. This report contains market size and forecasts of Varicella Virus Vaccine Live in global, including the following market information:
Global Varicella Virus Vaccine Live Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Varicella Virus Vaccine Live Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Varicella Virus Vaccine Live companies in 2022 (%)
The global Varicella Virus Vaccine Live market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Child Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Varicella Virus Vaccine Live include GSK, Merck, Sanofi, Green Cross, Shanghai Institute, BCHT, Changsheng, Keygen and Biken, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Varicella Virus Vaccine Live manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Varicella Virus Vaccine Live Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Varicella Virus Vaccine Live Market Segment Percentages, by Type, 2022 (%)
Child
Adult
Global Varicella Virus Vaccine Live Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Varicella Virus Vaccine Live Market Segment Percentages, by Application, 2022 (%)
Government Institution
Private Sector
Other
Global Varicella Virus Vaccine Live Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Varicella Virus Vaccine Live Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Varicella Virus Vaccine Live revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Varicella Virus Vaccine Live revenues share in global market, 2022 (%)
Key companies Varicella Virus Vaccine Live sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Varicella Virus Vaccine Live sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GSK
Merck
Sanofi
Green Cross
Shanghai Institute
BCHT
Changsheng
Keygen
Biken
Outline of Major Chapters:
Chapter 1: Introduces the definition of Varicella Virus Vaccine Live, market overview.
Chapter 2: Global Varicella Virus Vaccine Live market size in revenue and volume.
Chapter 3: Detailed analysis of Varicella Virus Vaccine Live manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Varicella Virus Vaccine Live in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Varicella Virus Vaccine Live capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Varicella Virus Vaccine Live Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Varicella Virus Vaccine Live Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Varicella Virus Vaccine Live Overall Market Size
2.1 Global Varicella Virus Vaccine Live Market Size: 2022 VS 2029
2.2 Global Varicella Virus Vaccine Live Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Varicella Virus Vaccine Live Sales: 2018-2029
3 Company Landscape
3.1 Top Varicella Virus Vaccine Live Players in Global Market
3.2 Top Global Varicella Virus Vaccine Live Companies Ranked by Revenue
3.3 Global Varicella Virus Vaccine Live Revenue by Companies
3.4 Global Varicella Virus Vaccine Live Sales by Companies
3.5 Global Varicella Virus Vaccine Live Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Varicella Virus Vaccine Live Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Varicella Virus Vaccine Live Product Type
3.8 Tier 1, Tier 2 and Tier 3 Varicella Virus Vaccine Live Players in Global Market
3.8.1 List of Global Tier 1 Varicella Virus Vaccine Live Companies
3.8.2 List of Global Tier 2 and Tier 3 Varicella Virus Vaccine Live Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Varicella Virus Vaccine Live Market Size Markets, 2022 & 2029
4.1.2 Child
4.1.3 Adult
4.2 By Type – Global Varicella Virus Vaccine Live Revenue & Forecasts
4.2.1 By Type – Global Varicella Virus Vaccine Live Revenue, 2018-2023
4.2.2 By Type – Global Varicella Virus Vaccine Live Revenue, 2024-2029
4.2.3 By Type – Global Varicella Virus Vaccine Live Revenue Market Share, 2018-2029
4.3 By Type – Global Varicella Virus Vaccine Live Sales & Forecasts
4.3.1 By Type – Global Varicella Virus Vaccine Live Sales, 2018-2023
4.3.2 By Type – Global Varicella Virus Vaccine Live Sales, 2024-2029
4.3.3 By Type – Global Varicella Virus Vaccine Live Sales Market Share, 2018-2029
4.4 By Type – Global Varicella Virus Vaccine Live Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Varicella Virus Vaccine Live Market Size, 2022 & 2029
5.1.2 Government Institution
5.1.3 Private Sector
5.1.4 Other
5.2 By Application – Global Varicella Virus Vaccine Live Revenue & Forecasts
5.2.1 By Application – Global Varicella Virus Vaccine Live Revenue, 2018-2023
5.2.2 By Application – Global Varicella Virus Vaccine Live Revenue, 2024-2029
5.2.3 By Application – Global Varicella Virus Vaccine Live Revenue Market Share, 2018-2029
5.3 By Application – Global Varicella Virus Vaccine Live Sales & Forecasts
5.3.1 By Application – Global Varicella Virus Vaccine Live Sales, 2018-2023
5.3.2 By Application – Global Varicella Virus Vaccine Live Sales, 2024-2029
5.3.3 By Application – Global Varicella Virus Vaccine Live Sales Market Share, 2018-2029
5.4 By Application – Global Varicella Virus Vaccine Live Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Varicella Virus Vaccine Live Market Size, 2022 & 2029
6.2 By Region – Global Varicella Virus Vaccine Live Revenue & Forecasts
6.2.1 By Region – Global Varicella Virus Vaccine Live Revenue, 2018-2023
6.2.2 By Region – Global Varicella Virus Vaccine Live Revenue, 2024-2029
6.2.3 By Region – Global Varicella Virus Vaccine Live Revenue Market Share, 2018-2029
6.3 By Region – Global Varicella Virus Vaccine Live Sales & Forecasts
6.3.1 By Region – Global Varicella Virus Vaccine Live Sales, 2018-2023
6.3.2 By Region – Global Varicella Virus Vaccine Live Sales, 2024-2029
6.3.3 By Region – Global Varicella Virus Vaccine Live Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Varicella Virus Vaccine Live Revenue, 2018-2029
6.4.2 By Country – North America Varicella Virus Vaccine Live Sales, 2018-2029
6.4.3 US Varicella Virus Vaccine Live Market Size, 2018-2029
6.4.4 Canada Varicella Virus Vaccine Live Market Size, 2018-2029
6.4.5 Mexico Varicella Virus Vaccine Live Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Varicella Virus Vaccine Live Revenue, 2018-2029
6.5.2 By Country – Europe Varicella Virus Vaccine Live Sales, 2018-2029
6.5.3 Germany Varicella Virus Vaccine Live Market Size, 2018-2029
6.5.4 France Varicella Virus Vaccine Live Market Size, 2018-2029
6.5.5 U.K. Varicella Virus Vaccine Live Market Size, 2018-2029
6.5.6 Italy Varicella Virus Vaccine Live Market Size, 2018-2029
6.5.7 Russia Varicella Virus Vaccine Live Market Size, 2018-2029
6.5.8 Nordic Countries Varicella Virus Vaccine Live Market Size, 2018-2029
6.5.9 Benelux Varicella Virus Vaccine Live Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Varicella Virus Vaccine Live Revenue, 2018-2029
6.6.2 By Region – Asia Varicella Virus Vaccine Live Sales, 2018-2029
6.6.3 China Varicella Virus Vaccine Live Market Size, 2018-2029
6.6.4 Japan Varicella Virus Vaccine Live Market Size, 2018-2029
6.6.5 South Korea Varicella Virus Vaccine Live Market Size, 2018-2029
6.6.6 Southeast Asia Varicella Virus Vaccine Live Market Size, 2018-2029
6.6.7 India Varicella Virus Vaccine Live Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Varicella Virus Vaccine Live Revenue, 2018-2029
6.7.2 By Country – South America Varicella Virus Vaccine Live Sales, 2018-2029
6.7.3 Brazil Varicella Virus Vaccine Live Market Size, 2018-2029
6.7.4 Argentina Varicella Virus Vaccine Live Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Varicella Virus Vaccine Live Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Varicella Virus Vaccine Live Sales, 2018-2029
6.8.3 Turkey Varicella Virus Vaccine Live Market Size, 2018-2029
6.8.4 Israel Varicella Virus Vaccine Live Market Size, 2018-2029
6.8.5 Saudi Arabia Varicella Virus Vaccine Live Market Size, 2018-2029
6.8.6 UAE Varicella Virus Vaccine Live Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 GSK
7.1.1 GSK Company Summary
7.1.2 GSK Business Overview
7.1.3 GSK Varicella Virus Vaccine Live Major Product Offerings
7.1.4 GSK Varicella Virus Vaccine Live Sales and Revenue in Global (2018-2023)
7.1.5 GSK Key News & Latest Developments
7.2 Merck
7.2.1 Merck Company Summary
7.2.2 Merck Business Overview
7.2.3 Merck Varicella Virus Vaccine Live Major Product Offerings
7.2.4 Merck Varicella Virus Vaccine Live Sales and Revenue in Global (2018-2023)
7.2.5 Merck Key News & Latest Developments
7.3 Sanofi
7.3.1 Sanofi Company Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Varicella Virus Vaccine Live Major Product Offerings
7.3.4 Sanofi Varicella Virus Vaccine Live Sales and Revenue in Global (2018-2023)
7.3.5 Sanofi Key News & Latest Developments
7.4 Green Cross
7.4.1 Green Cross Company Summary
7.4.2 Green Cross Business Overview
7.4.3 Green Cross Varicella Virus Vaccine Live Major Product Offerings
7.4.4 Green Cross Varicella Virus Vaccine Live Sales and Revenue in Global (2018-2023)
7.4.5 Green Cross Key News & Latest Developments
7.5 Shanghai Institute
7.5.1 Shanghai Institute Company Summary
7.5.2 Shanghai Institute Business Overview
7.5.3 Shanghai Institute Varicella Virus Vaccine Live Major Product Offerings
7.5.4 Shanghai Institute Varicella Virus Vaccine Live Sales and Revenue in Global (2018-2023)
7.5.5 Shanghai Institute Key News & Latest Developments
7.6 BCHT
7.6.1 BCHT Company Summary
7.6.2 BCHT Business Overview
7.6.3 BCHT Varicella Virus Vaccine Live Major Product Offerings
7.6.4 BCHT Varicella Virus Vaccine Live Sales and Revenue in Global (2018-2023)
7.6.5 BCHT Key News & Latest Developments
7.7 Changsheng
7.7.1 Changsheng Company Summary
7.7.2 Changsheng Business Overview
7.7.3 Changsheng Varicella Virus Vaccine Live Major Product Offerings
7.7.4 Changsheng Varicella Virus Vaccine Live Sales and Revenue in Global (2018-2023)
7.7.5 Changsheng Key News & Latest Developments
7.8 Keygen
7.8.1 Keygen Company Summary
7.8.2 Keygen Business Overview
7.8.3 Keygen Varicella Virus Vaccine Live Major Product Offerings
7.8.4 Keygen Varicella Virus Vaccine Live Sales and Revenue in Global (2018-2023)
7.8.5 Keygen Key News & Latest Developments
7.9 Biken
7.9.1 Biken Company Summary
7.9.2 Biken Business Overview
7.9.3 Biken Varicella Virus Vaccine Live Major Product Offerings
7.9.4 Biken Varicella Virus Vaccine Live Sales and Revenue in Global (2018-2023)
7.9.5 Biken Key News & Latest Developments
8 Global Varicella Virus Vaccine Live Production Capacity, Analysis
8.1 Global Varicella Virus Vaccine Live Production Capacity, 2018-2029
8.2 Varicella Virus Vaccine Live Production Capacity of Key Manufacturers in Global Market
8.3 Global Varicella Virus Vaccine Live Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Varicella Virus Vaccine Live Supply Chain Analysis
10.1 Varicella Virus Vaccine Live Industry Value Chain
10.2 Varicella Virus Vaccine Live Upstream Market
10.3 Varicella Virus Vaccine Live Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Varicella Virus Vaccine Live Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Varicella Virus Vaccine Live in Global Market
Table 2. Top Varicella Virus Vaccine Live Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Varicella Virus Vaccine Live Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Varicella Virus Vaccine Live Revenue Share by Companies, 2018-2023
Table 5. Global Varicella Virus Vaccine Live Sales by Companies, (K Units), 2018-2023
Table 6. Global Varicella Virus Vaccine Live Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Varicella Virus Vaccine Live Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Varicella Virus Vaccine Live Product Type
Table 9. List of Global Tier 1 Varicella Virus Vaccine Live Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Varicella Virus Vaccine Live Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Varicella Virus Vaccine Live Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Varicella Virus Vaccine Live Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Varicella Virus Vaccine Live Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Varicella Virus Vaccine Live Sales (K Units), 2018-2023
Table 15. By Type - Global Varicella Virus Vaccine Live Sales (K Units), 2024-2029
Table 16. By Application – Global Varicella Virus Vaccine Live Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Varicella Virus Vaccine Live Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Varicella Virus Vaccine Live Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Varicella Virus Vaccine Live Sales (K Units), 2018-2023
Table 20. By Application - Global Varicella Virus Vaccine Live Sales (K Units), 2024-2029
Table 21. By Region – Global Varicella Virus Vaccine Live Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Varicella Virus Vaccine Live Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Varicella Virus Vaccine Live Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Varicella Virus Vaccine Live Sales (K Units), 2018-2023
Table 25. By Region - Global Varicella Virus Vaccine Live Sales (K Units), 2024-2029
Table 26. By Country - North America Varicella Virus Vaccine Live Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Varicella Virus Vaccine Live Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Varicella Virus Vaccine Live Sales, (K Units), 2018-2023
Table 29. By Country - North America Varicella Virus Vaccine Live Sales, (K Units), 2024-2029
Table 30. By Country - Europe Varicella Virus Vaccine Live Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Varicella Virus Vaccine Live Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Varicella Virus Vaccine Live Sales, (K Units), 2018-2023
Table 33. By Country - Europe Varicella Virus Vaccine Live Sales, (K Units), 2024-2029
Table 34. By Region - Asia Varicella Virus Vaccine Live Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Varicella Virus Vaccine Live Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Varicella Virus Vaccine Live Sales, (K Units), 2018-2023
Table 37. By Region - Asia Varicella Virus Vaccine Live Sales, (K Units), 2024-2029
Table 38. By Country - South America Varicella Virus Vaccine Live Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Varicella Virus Vaccine Live Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Varicella Virus Vaccine Live Sales, (K Units), 2018-2023
Table 41. By Country - South America Varicella Virus Vaccine Live Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Varicella Virus Vaccine Live Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Varicella Virus Vaccine Live Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Varicella Virus Vaccine Live Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Varicella Virus Vaccine Live Sales, (K Units), 2024-2029
Table 46. GSK Company Summary
Table 47. GSK Varicella Virus Vaccine Live Product Offerings
Table 48. GSK Varicella Virus Vaccine Live Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. GSK Key News & Latest Developments
Table 50. Merck Company Summary
Table 51. Merck Varicella Virus Vaccine Live Product Offerings
Table 52. Merck Varicella Virus Vaccine Live Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Merck Key News & Latest Developments
Table 54. Sanofi Company Summary
Table 55. Sanofi Varicella Virus Vaccine Live Product Offerings
Table 56. Sanofi Varicella Virus Vaccine Live Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Sanofi Key News & Latest Developments
Table 58. Green Cross Company Summary
Table 59. Green Cross Varicella Virus Vaccine Live Product Offerings
Table 60. Green Cross Varicella Virus Vaccine Live Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Green Cross Key News & Latest Developments
Table 62. Shanghai Institute Company Summary
Table 63. Shanghai Institute Varicella Virus Vaccine Live Product Offerings
Table 64. Shanghai Institute Varicella Virus Vaccine Live Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Shanghai Institute Key News & Latest Developments
Table 66. BCHT Company Summary
Table 67. BCHT Varicella Virus Vaccine Live Product Offerings
Table 68. BCHT Varicella Virus Vaccine Live Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. BCHT Key News & Latest Developments
Table 70. Changsheng Company Summary
Table 71. Changsheng Varicella Virus Vaccine Live Product Offerings
Table 72. Changsheng Varicella Virus Vaccine Live Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Changsheng Key News & Latest Developments
Table 74. Keygen Company Summary
Table 75. Keygen Varicella Virus Vaccine Live Product Offerings
Table 76. Keygen Varicella Virus Vaccine Live Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Keygen Key News & Latest Developments
Table 78. Biken Company Summary
Table 79. Biken Varicella Virus Vaccine Live Product Offerings
Table 80. Biken Varicella Virus Vaccine Live Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Biken Key News & Latest Developments
Table 82. Varicella Virus Vaccine Live Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 83. Global Varicella Virus Vaccine Live Capacity Market Share of Key Manufacturers, 2021-2023
Table 84. Global Varicella Virus Vaccine Live Production by Region, 2018-2023 (K Units)
Table 85. Global Varicella Virus Vaccine Live Production by Region, 2024-2029 (K Units)
Table 86. Varicella Virus Vaccine Live Market Opportunities & Trends in Global Market
Table 87. Varicella Virus Vaccine Live Market Drivers in Global Market
Table 88. Varicella Virus Vaccine Live Market Restraints in Global Market
Table 89. Varicella Virus Vaccine Live Raw Materials
Table 90. Varicella Virus Vaccine Live Raw Materials Suppliers in Global Market
Table 91. Typical Varicella Virus Vaccine Live Downstream
Table 92. Varicella Virus Vaccine Live Downstream Clients in Global Market
Table 93. Varicella Virus Vaccine Live Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Varicella Virus Vaccine Live Segment by Type in 2022
Figure 2. Varicella Virus Vaccine Live Segment by Application in 2022
Figure 3. Global Varicella Virus Vaccine Live Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Varicella Virus Vaccine Live Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Varicella Virus Vaccine Live Revenue, 2018-2029 (US$, Mn)
Figure 7. Varicella Virus Vaccine Live Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Varicella Virus Vaccine Live Revenue in 2022
Figure 9. By Type - Global Varicella Virus Vaccine Live Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Varicella Virus Vaccine Live Revenue Market Share, 2018-2029
Figure 11. By Type - Global Varicella Virus Vaccine Live Sales Market Share, 2018-2029
Figure 12. By Type - Global Varicella Virus Vaccine Live Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Varicella Virus Vaccine Live Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Varicella Virus Vaccine Live Revenue Market Share, 2018-2029
Figure 15. By Application - Global Varicella Virus Vaccine Live Sales Market Share, 2018-2029
Figure 16. By Application - Global Varicella Virus Vaccine Live Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Varicella Virus Vaccine Live Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Varicella Virus Vaccine Live Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Varicella Virus Vaccine Live Revenue Market Share, 2018-2029
Figure 20. By Region - Global Varicella Virus Vaccine Live Sales Market Share, 2018-2029
Figure 21. By Country - North America Varicella Virus Vaccine Live Revenue Market Share, 2018-2029
Figure 22. By Country - North America Varicella Virus Vaccine Live Sales Market Share, 2018-2029
Figure 23. US Varicella Virus Vaccine Live Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Varicella Virus Vaccine Live Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Varicella Virus Vaccine Live Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Varicella Virus Vaccine Live Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Varicella Virus Vaccine Live Sales Market Share, 2018-2029
Figure 28. Germany Varicella Virus Vaccine Live Revenue, (US$, Mn), 2018-2029
Figure 29. France Varicella Virus Vaccine Live Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Varicella Virus Vaccine Live Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Varicella Virus Vaccine Live Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Varicella Virus Vaccine Live Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Varicella Virus Vaccine Live Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Varicella Virus Vaccine Live Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Varicella Virus Vaccine Live Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Varicella Virus Vaccine Live Sales Market Share, 2018-2029
Figure 37. China Varicella Virus Vaccine Live Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Varicella Virus Vaccine Live Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Varicella Virus Vaccine Live Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Varicella Virus Vaccine Live Revenue, (US$, Mn), 2018-2029
Figure 41. India Varicella Virus Vaccine Live Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Varicella Virus Vaccine Live Revenue Market Share, 2018-2029
Figure 43. By Country - South America Varicella Virus Vaccine Live Sales Market Share, 2018-2029
Figure 44. Brazil Varicella Virus Vaccine Live Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Varicella Virus Vaccine Live Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Varicella Virus Vaccine Live Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Varicella Virus Vaccine Live Sales Market Share, 2018-2029
Figure 48. Turkey Varicella Virus Vaccine Live Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Varicella Virus Vaccine Live Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Varicella Virus Vaccine Live Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Varicella Virus Vaccine Live Revenue, (US$, Mn), 2018-2029
Figure 52. Global Varicella Virus Vaccine Live Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Varicella Virus Vaccine Live by Region, 2022 VS 2029
Figure 54. Varicella Virus Vaccine Live Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 水痘ウイルス生ワクチンの世界市場見通し2023年-2029年(Varicella Virus Vaccine Live Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

水痘ウイルス生ワクチンの世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp